carbenoxolone sodium has been researched along with fludrocortisone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mantero, F | 1 |
| Arai, K; Chrousos, GP; Irony, I; Karl, M; Listwak, S; Suzuki, Y; Tsigos, C | 1 |
| Speiser, PW | 1 |
| Cutler, GB; Irony, I | 1 |
1 review(s) available for carbenoxolone sodium and fludrocortisone
| Article | Year |
|---|---|
Exogenous mineralocorticoid-like disorders.
Topics: Adult; Aldosterone; Animals; Carbenoxolone; Emollients; Female; Fludrocortisone; Fluprednisolone; Glycyrrhiza; Humans; Hyperkalemia; Hypertension; Hypokalemia; Kidney Tubules; Male; Middle Aged; Mineralocorticoids; Nasal Decongestants; Plant Extracts; Plants, Medicinal; Potassium; Renin; Syndrome | 1981 |
3 other study(ies) available for carbenoxolone sodium and fludrocortisone
| Article | Year |
|---|---|
Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy.
Topics: Adolescent; Base Sequence; Blotting, Southern; Carbenoxolone; Dexamethasone; DNA; DNA, Complementary; Fludrocortisone; Genome; Humans; Male; Molecular Probes; Molecular Sequence Data; Pseudohypoaldosteronism; Receptors, Mineralocorticoid; Time Factors | 1994 |
Toward better treatment of congenital adrenal hyperplasia.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenal Hyperplasia, Congenital; Adult; Carbenoxolone; Child; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fludrocortisone; Humans; Hydrocortisone; Hydroxysteroid Dehydrogenases; Male; Mineralocorticoids | 1999 |
Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Carbenoxolone; Cholinesterase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fludrocortisone; Growth Hormone-Releasing Hormone; Hormones; Humans; Hydrocortisone; Hydroxysteroid Dehydrogenases; Hypothalamo-Hypophyseal System; Male; Mineralocorticoids; Pilot Projects; Pituitary-Adrenal System; Pyridostigmine Bromide; Renin | 1999 |